G25.7 Other and unspecified drug induced movement disorders

Name of the Condition

• Other and Unspecified Drug Induced Movement Disorders
• ICD-10 Code: G25.7

Summary

Other and unspecified drug induced movement disorders are a category of conditions resulting from medication use that disrupt normal movement patterns. These disorders involve involuntary movements or altered motor control due to pharmaceutical agents, with the term "other" indicating specific but less common types and "unspecified" meaning the precise disorder has not been defined.

Causes

These disorders are caused by medications that affect neurotransmitter systems, particularly dopamine, in the brain. Drugs such as antipsychotics, antiemetics, antidepressants, and certain anticonvulsants can interfere with motor pathways, leading to movement abnormalities. The specific mechanism depends on the drug's pharmacological action.

Risk Factors

• Use of medications known to affect motor function
• High doses or prolonged treatment with such drugs
• Pre-existing neurological vulnerabilities
• Advanced age, which may increase susceptibility to side effects

Symptoms

• Involuntary muscle movements (e.g., dystonia, akathisia, or chorea)
• Tremors or rhythmic shaking
• Muscle rigidity or stiffness
• Restlessness or inability to stay still
• Abnormal postures or repetitive motions

Diagnosis

Diagnosis involves a clinical evaluation of symptoms and medication history, followed by a neurological examination to assess movement patterns. Differential diagnosis is used to rule out other neurological conditions, and medication review helps identify potential causative agents.

Treatment Options

• Discontinuation or dose adjustment of the offending drug
• Use of medications like anticholinergics or benzodiazepines to manage symptoms
• Physical therapy to improve motor control and coordination

Prognosis and Follow-Up

Prognosis depends on the specific disorder and timely intervention. Symptoms often improve after stopping or modifying the causative medication. Regular follow-up is necessary to monitor for recurrence or new symptoms, especially if alternative treatments are initiated.

Complications

• Persistent movement abnormalities if the drug is not discontinued
• Functional impairment affecting daily activities
• Psychological distress due to visible symptoms
• Potential for falls or injuries from uncontrolled movements

Lifestyle & Prevention

• Avoid medications known to cause movement disorders when possible
• Use the lowest effective dose of necessary drugs
• Regularly review medication lists with healthcare providers
• Engage in exercises that support motor function and balance

When to Seek Professional Help

Seek medical attention if involuntary movements develop after starting a new medication, worsen over time, or interfere with daily tasks. Prompt evaluation can help identify the cause and prevent complications.

Tips for Medical Coders

Document the specific drug or class of drugs associated with the movement disorder, as well as the clinical presentation, to support accurate coding. For unspecified cases, ensure documentation reflects the lack of further detail. Include any relevant medication history or adjustments made during treatment.